EFFICACY, SAFETY AND TOLERABILITY OF RECOMBINANT HUMAN HYALURONIDASE-FACILITATED SUBCUTANEOUS INFUSION OF IMMUNOGLOBULIN G IN ADULT PATIENTS WITH PRIMARY IMMUNODEFICIENCIES: PHASE 3 STUDY RESULTS

被引：0

作者：

Stein, Mark ^{[1
]}

Wasserman, Richard L. ^{[2
]}

Melamed, Isaac ^{[3
]}

Rubinstein, Arye ^{[4
,5
]}

Puck, Jennifer ^{[6
]}

Gupta, Sudhir ^{[7
]}

Engl, Werner ^{[8
]}

Leibl, Heinz ^{[8
]}

McCoy, Barbara ^{[8
]}

Yel, Leman ^{[9
]}

Schiff, Richard I. ^{[9
]}

机构：

[1] Allergy Associates Palm Beaches, North Palm Beach, FL USA

[2] DallasAllergyImmunol, Dallas, TX USA

[3] IMMUNOe Hlth Ctr, Centennial, CO USA

[4] Albert Einstein Coll Med, Bronx, NY 10467 USA

[5] Montefiore Hosp, Bronx, NY USA

[6] Univ Calif San Francisco, San Francisco, CA 94143 USA

[7] Univ Calif Irvine, Irvine, CA USA

[8] Baxter BioSci, Vienna, Austria

[9] Baxter BioSci, Westlake Village, CA USA

来源：

JOURNAL OF CLINICAL IMMUNOLOGY | 2014年 / 34卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：727 / 727

页数：1

共 50 条

[31] Efficacy, Safety, Tolerability, and Serum IgG Trough Levels of Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% in US Pediatric Patients with Primary Immunodeficiency Diseases
Niraj C. Patel
Jolan E. Walter
Richard L. Wasserman
Arye Rubinstein
Suthida Kankirawatana
Meagan W. Shepherd
Erin Greco
Zhaoyang Li
Sharon Russo-Schwarzbaum
Shumyla Saeed-Khawaja
Barbara McCoy
Leman Yel
Journal of Clinical Immunology, 2025, 45 (1)
[32] LONG TERM SAFETY, EFFICACY AND TOLERABILITY OF RECOMBINANT HUMAN HYALURONIDASE [RHUPH20]-FACILITATED SUBCUTANEOUS (SC) INFUSION OF IMMUNOGLOBULIN G (IGG) (HYQVIA; IGHY) IN PEDIATRIC PATIENTS AGED <16 YEARS WITH PRIMARY IMMUNODEFICIENCIES (PID)
Wasserman, Richard L.
Melamed, Isaac
Stein, Mark
Kobrynski, Lisa
Puck, Jennifer
Gupta, Sudhir
Engl, Werner
McCoy, Barbara
Leibl, Heinz
Yel, Leman
JOURNAL OF CLINICAL IMMUNOLOGY, 2015, 35 (03) : 314 - 314
[33] RECOMBINANT HUMAN HYALURONIDASE-FACILITATED SUBCUTANEOUS IMMUNOGLOBULIN FOR IDIOPATHIC INFLAMMATORY MYOSITIS: A MULTICENTER OBSERVATIONAL STUDY
Palermo, A.
Bettiol, A.
Urban, M. L.
Barilaro, A.
Danieli, M. G.
Capassoni, M.
Guiducci, S.
Campochiaro, C.
Dagna, L.
Canti, V.
Rovere-Querini, P.
Cardelli, C.
Mosca, M.
Emmi, G.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 761 - 761
[34] Long-Term Tolerability and Safety Of Facilitated-Subcutaneous Infusion Of Human Immune Globulin G (IgG), 10%, and Recombinant Human Hyaluronidase (rHuPH20) (IGHy): A Phase 3 Extension Study In Patients With Primary Immunodeficiencies (PIs)
Melamed, Isaac Reuven
Wasserman, Richard L.
Stein, Mark
Rubinstein, Arye
Puck, Jennifer M.
Gupta, Sudhir
Engl, Werner
Leibl, Heinz
Yel, Leman
Schiff, Richard I.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB180 - AB180
[35] RECOMBINANT HUMAN HYALURONIDASE-FACILITATED SUBCUTANEOUS IMMUNOGLOBULIN FOR IDIOPATHIC INFLAMMATORY MYOSITIS: A MULTICENTER OBSERVATIONAL STUDY
Palermo, Adalgisa
Bettiol, Alessandra
Urban, Maria L.
Barilaro, Alessandro
Danieli, Maria G.
Capassoni, Marco
Guiducci, Serena
Campochiaro, Corrado
Dagna, Lorenzo
Brussino, Luisa
Canti, Valentina
Rovere-Querini, Patrizia
Cardelli, Chiara
Mosca, Marta
Emmi, Giacomo
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (02) : 497 - 497
[36] Local Adverse Reactions Decreased Over Time During Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Immunoglobulin G (FSCIG) Treatment in Patients with PID
Stein, Mark
Wasserman, Richard L.
Melamed, Isaac
Gupta, Sudhir
Kobrynski, Lisa
Rubinstein, Arye
Rabbat, Christopher J.
Engl, Werner
McCoy, Barbara
Leibl, Heinz
Yel, Leman
JOURNAL OF CLINICAL IMMUNOLOGY, 2017, 37 : S54 - S54
[37] LONG-TERM SAFETY AND PHARMACOKINETICS OF FACILITATED-SUBCUTANEOUS INFUSION OF HUMAN IMMUNOGLOBULIN G, 10%, AND RECOMBINANT HUMAN HYALURONIDASE (IGHY): PHASE 3 EXTENSION STUDY IN PRIMARY IMMUNODEFICIENCY DISEASE
Melamed, I.
Wasserman, R. L.
Stein, M.
Rubenstein, A.
Puck, J.
Gupta, S.
Engl, W.
Leibl, H.
Gelmont, D.
Schiff, R. I.
JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 : 132 - 133
[38] Tolerability and Efficacy of Facilitated-Subcutaneous Infusion of Immune Globulin (Human), 10% and Recombinant Human Hyaluronidase (Ighy) In Patients With Primary Immunodeficiency (Pi)
Stein, Mark
Wasserman, Richard
Melamed, Isaac
Rubinstein, Arye
Engl, Werner
Leibl, Heinz
McCoy, Barbara
Gelmont, David
Schiff, Richard
JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 (02) : 354 - 354
[39] Local Adverse Reaction Rates Decreased over Time during Treatment with Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Immunoglobulin G (IGHy) in Patients with Primary Immunodeficiency Disorders in the IGHy Phase 3 Studies
Stein, Mark R.
Wasserman, Richard L.
Melamed, Isaac
Gupta, Sudhir
Kobrynski, Lisa J.
Rubinstein, Arye
Rabbat, Christopher J.
Engl, Werner
McCoy, Barbara
Leibl, Heinz
Yel, Leman
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB220 - AB220
[40] POST-AUTHORIZATION SAFETY STUDY OF HYALURONIDASE-FACILITATED SUBCUTANEOUS IMMUNOGLOBULIN 10% TREATMENT IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES
Rubinstein, A.
Bridges, T.
McNeil, D.
Tachdjian, R.
Wedner, H.
Wasserman, R.
Leibl, H.
Rabbat, C.
Honigberg, R.
Yel, L.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S71 - S71

← 1 2 3 4 5 →